SecBot SecBot

SPRC

SciSparc Ltd.
Nasdaq· Pharmaceutical Preparations· Inc. L3· CIK 0001611746 Biotech & Drug Discovery
$0.8500 −0.44 (−34.11%)
Oct 27 4:00 PM ET · prev $1.29
Market cap
$633.3K
Nano cap
1 year
−97.4%
from $33.12 · Oct 28
30 days
−82.7%
from $4.91
52-week range
$0.8500–33.12
at the low
Avg volume 20D
4.12M
Oct 26 spike 38.37M
Short interest
12.1K
≈2.1% of shares · +6.7%
Days to cover
1.0
at average volume
Insider net
−$4.6K
0 buyers · 1 seller · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Reddit crowd
50°
Neutral · 2 mentions this week
Filing reports
16
analyzed by SecBot
SecBot read BEARISH 15 reports · 90 days
Balance 3 bearish · 0 bullish · 12 neutral oldest → newest, height = score
Avg score ·High conf. 4/15
Strongest BEARISH SciSparc entered into an inducement letter with L.I.A Pure Capital Ltd. to convert $2,023,039.21 of…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBEARISH

    1 insider sold $4.6K.

  • InstitutionsMIXED

    Q2 2026: 1 added (0 new), 0 trimmed or exited.

  • Short sellersSTEADY

    Short interest +6.7% to 12.1K shares. 1.0 days to cover, ≈2.1% of shares.

  • TrendDOWNTREND

    81% below its 50-day average. New closing low $0.8500 on Oct 27.

  • SocialQUIET

    Crowd 50° (neutral) this week from 2 mentions: 0 bullish, 0 bearish. No setup call.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
UBS Group AGADD4,518$24.9K

Quarterly 13F filings are due 45 days after each quarter ends.

Reddit mentions per day, 14 days
Crowd this week 50° Neutral 0 bullish · 0 bearish
Mentions, 7 days 2 1 in posts · 1 in comments
Recent posts
r/smallstreetbets Neutral 2d ago
⚡MORNING WATCHLIST⚡
1 upvotes · 3 comments
r/pennystocks Neutral 13d ago
15 OCT 2026 , WHAT ARE THE BIGGEST WINNERS AND WHY ?
3 upvotes · 4 comments
Recent comments
r/pennystocks Neutral 2d ago
Stocks I am watching VEEA...nice move AF...will look for dip and volume before possibly getting in. GCDT...huge volume. Could make a nice move or be a great scalp play. SPRC...big move today on nice volume...watching for dip and volume continuation before possibly getting in FMFC...low float play AIXI...continued momentum...looking for volume TCRT...reversal play after big drop UCFI..been halted. Not sure why...watching Oil stocks with war and oil prices As always look for dips and
All social signals and their track records

Insider ledger

Form 4
$0
bought · 0 insiders
$4.6K
sold · 1 insider
DateInsiderTypeValue
Jun 1, 2026
Shrem Itschak
Director
SELL$4.6K

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 22, 2026
Announcement
SciSparc: Subsidiary NeuroThera Labs Reports Positive Progress in FDA-Approved Phase IIb Clinical Trial for Tourette Syndrome
TEL AVIV, Israel, Oct. 22, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that its subsidiary,...
Oct 19, 2026
Press release
SciSparc Shifts Focus to Agentic AI, Targeting Cybersecurity and Finance Applications
TEL AVIV, Israel, Oct. 19, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), announced that it will shift its…
Oct 15, 2026
Trading halt
Halt Resumed: SPRC — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-10-15T18:43:49.000Z | Resumed 2026-10-15T18:48:49.000Z
Oct 15, 2026
Trading halt
Trading Halt: SPRC — LUDP (Volatility Trading Pause)
SciSparc Ltd Os | Market: NASDAQ | Code: LUDP — Volatility Trading Pause
Oct 15, 2026
Trading halt
Halt Resumed: SPRC — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-10-15T18:30:25.000Z | Resumed 2026-10-15T18:35:25.000Z

Short side

FINRA· Oct 15, 2026
12,131
shares short
+6.7%
vs prior settlement
1.0
days to cover
≈2.1%
of shares outstanding
Trading halts
Oct 15, 2026Volatility PauseResumed
Oct 15, 2026Volatility PauseResumed
Oct 15, 2026Volatility PauseResumed
Oct 15, 2026Volatility PauseResumed
Oct 15, 2026Volatility PauseResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 26, 2026 SEC
SciSparc entered into an inducement letter with L.I.A Pure Capital to exercise warrants for 405,728 shares at a…
6-K — Impact 5/10
Oct 23, 2026 SEC
SciSparc subsidiary NeuroThera Labs announced operational progress in its FDA-approved Phase IIb trial of SCI-110 for…
6-K — Impact 4/10
Oct 22, 2026 Press
SciSparc subsidiary NeuroThera Labs announced completion of manufacturing and QP batch release certification for…
Impact 4/10
Oct 22, 2026 Announcement
SciSparc: Subsidiary NeuroThera Labs Reports Positive Progress in FDA-Approved Phase IIb Clinical Trial for Tourette Syndrome
TEL AVIV, Israel, Oct. 22, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciS
Oct 15, 2026 SEC
SciSparc entered into an inducement letter with L.I.A Pure Capital Ltd. to convert $2,023,039.21 of outstanding…
6-K — Impact 7/10
Oct 15, 2026 Press
SciSparc announced a strategic shift toward Agentic AI-powered technologies, including cybersecurity and finance…
Impact 3/10
Jun 30, 2026 Inst.
UBS Group AG — ADD
4,518 shares ($24.9K)
Jun 1, 2026 Insider
Shrem Itschak sold 462 shares
Director @ $10.00 ($4.6K)

SecBot reports

16 filings · 11 press releases · 0 bullish · 3 bearish · 13 neutral
All SPRC filing & press-release reports (27)